FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061186 [Registered on: 08/01/2024] Trial Registered Prospectively
Last Modified On: 01/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing the study between two blood products to form new bone. 
Scientific Title of Study   Comparative Evaluation of concentrated growth factor with platelet rich fibrin for the treatment of infrabony defects- A randomized controlled study. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Angela Johnson 
Designation  Post graduate student  
Affiliation  K M Shah dental college and hospital 
Address  Sumandeep vidyapeeth At and Po pipariya, Ta.Waghodia dist.Vadodara
Room no. 7, Department of Periodontology, K.M Shah dental college and hospital,Sumandeep vidyapeeth AT And PO Pipariya, TA.Waghodia Dist.vadodara, gujarat- 391760
Vadodara
GUJARAT
391760
India 
Phone  9702004902  
Fax    
Email  angelajohnson250796@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Monali Shah 
Designation  HOD, professor and Guide 
Affiliation  K M Shah dental college and hospital 
Address  Sumandeep vidyapeeth At and Po pipariya, Ta.waghodia dist.Vadodara
Room no. 7, Department of periodontology, K.M Shah dental college and hospital,Sumandeep vidyapeeth At and Po pipariya, Ta.Waghodia dist.vadodara, gujarat- 391760
Vadodara
GUJARAT
391760
India 
Phone  9824003228  
Fax    
Email  smonali2011@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Angela Johnson 
Designation  Post graduate student  
Affiliation  K M Shah dental college and hospital 
Address  Sumandeep vidyapeeth AT and PO pipariya, TA.waghodia dist.vadodara
Room no. 7, department of periodontology, K.M Shah dental college and hospital,Sumandeep vidyapeeth AT and PO pipariya, TA.waghodia dist.vadodara, gujarat- 391760
Vadodara
GUJARAT
391760
India 
Phone  9702004902  
Fax    
Email  angelajohnson250796@gmail.com  
 
Source of Monetary or Material Support  
KM Shah dental college and hospital,sumandeep vidyapeeth At and Po pipariya, Ta.waghodia dist.vadodara, gujarat-391760 
 
Primary Sponsor  
Name  Dr Angela Johnson 
Address  Sumandeep vidyapeeth At and Po pipariya, Ta.waghodia dist.vadodara- 391760, gujarat 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Monali Shah   Room No. 7, Department of periodontology, KM Shah dental college and hospital, Sumandeep University, Pipariya, Waghodia Road, Vadodara, Gujarat-391760. 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Angela Johnson  KM Shah dental college and hospital  Room no. 7, department of periodontology, 2nd floor.
Vadodara
GUJARAT 
9702004902

angelajohnson250796@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sumandeep Vidyapeeth Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Concentrated growth factors  Concentrated growth factor promote periodontal regeneration and is used in the treatment of periodontal intrabony defects. It is an excellent material for enhancing bone healing. 
Comparator Agent  Platelet Rich Fibrin  It is an autologous non- transfusional hemo-component. The dense fibrin matrix contains leukocytes, platelets, and growth factors, and it can be employed as a biomaterial for healing. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Systemically healthy Participants diagnosed with localized or generalized Stage II/III
periodontitis within the age group of 18-50 years.
2. Participants with at least one tooth with probing depth (PPD) > 5mm and presence of
infrabony component (IC) >3mm site after phase I therapy. 
 
ExclusionCriteria 
Details  1. Pregnant and lactating women
2. Medications which interfere with platelet
function within last three months and
antibiotics taken within 1 month prior to
treatment.
3. Patients with systemic disease.
4. History of Smoking or tobacco consumption.
5. Patients with poor oral hygiene or previous
lack of cooperation with the maintenance
program. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Relative attachment levels
2.Probing depth
3.Bleeding index
 
Baseline - on the day of the surgery and at 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
1.Radiographic bone level
2.Bone fill % 
Baseline - on the day of the surgery and at 3 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   11/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Periodontitis is a chronic, inflammatory, non-communicable condition that damages the periodontium in all ways and cannot be reversed. It is a localized inflammatory response caused by bacterial infection of a periodontal pocket associated with subgingival plaque.The early stages of the disease (gingivitis), inflammation is limited to the gingiva, but in periodontitis, it spreads to deeper tissues, causing swelling, bleeding, and poor smell in the gingiva. When the condition progresses, the periodontium’s supporting collagen degenerates, alveolar bone starts to resorb, and gingival epithelium migrates along the tooth’s surface to produce a "periodontal pocket. The course of periodontitis starts with pocket formation induced by bacterial plaque and a subsequent alveolar bone destruction typical of chronic periodontitis. Bone destruction during periodontitis can be of different morphological patterns including horizontal defects and vertical defects. Periodontal defects can be differentiated based on bone resorption patterns into ‘supraosseous’ (‘suprabony’) and ‘infraosseous’ (‘infrabony’). An infrabony defect is the anatomical consequence of the dental plaque’s apical advancement during the course of the disease. Suprabony defects are those in which the base of the pocket is positioned proximal to the alveolar crest. On the other hand, infrabony defects are those in which the base of the pocket is located apically in relation to the bone crest.Such defects, if left untreated, easily promote periodontitis progression and further loss of attachment. There are many surgical procedures have been developed in an effort to treat periodontitis effectively. One of the earliest and most promising techniques is open flap debridement (OFD). Open flap debridement (OFD) has been shown to result in successful treatment of intrabony defects. A high concentration of platelets make up platelet-rich fibrin (PRF), an autologous non- transfusional hemo-component. The dense fibrin matrix contains leukocytes, platelets, and growth factors, and it can be employed as a biomaterial for healing. PDGF-AB (platelet- derived growth factor AB), TGFß-1 (transforming growth factor ß-1), and VEGF are all found in platelets (vascular endothelial growth factor). These growth factors promote angiogenesis, matrix remodelling, and cell proliferation. Concentrated growth factor (CGFs) are a new generation of platelets concentrates, which contain abundant growth factor. CGFs promote periodontal regeneration and is used in the treatment of periodontal intrabony defects. Concentrated growth factor (CGF) is an excellent material for enhancing bone healing and stimulatory effect on angiogenesis and epithelialization. So concentrated growth factor can be used  for the treatment of infrabony defects. 
Close